top of page
Ecosystem
Beta Site
Blog: Blog2
GPCR News
Search
Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
May 2022 "MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique...
GPCR News
May 1, 20221 min read
2 views
0 comments
Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) –...
GPCR News
Mar 1, 20221 min read
2 views
0 comments
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
January 2022 Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update...
GPCR News
Jan 1, 20221 min read
5 views
0 comments
bottom of page